NVCT · Nuvectis Pharma, Inc.
$19.08
+1.05 (+5.82%)
At close · Jul 21
Market Cap
$511.68M
Shares
26.53M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$26.44M
-39.2%
FY2025
Diluted EPS
-$1.32
-18.9%
FY2025
Operating Cash Flow
-$16.01M
-30.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| $18.58M | $18.15M | $12.92M | $15.38M | $13.23M | |
| $9.69M | $9.42M | $6.93M | $7.52M | $6.01M | |
| -$28.27M | -$27.57M | -$19.85M | -$22.9M | -$19.23M | |
| -$27.16M | -$26.44M | -$19M | -$22.26M | -$19.09M | |
| -$29.59M | -$28.87M | -$19M | -$22.26M | -$19.09M | |
| USD/shares | — | -$1.32 | -$1.11 | -$1.43 | -$1.51 |
| USD/shares | — | -$1.32 | -$1.11 | -$1.43 | -$1.51 |
| shares | — | 21.81M | 17.11M | 15.56M | 12.66M |
| shares | — | 21.81M | 17.11M | 15.56M | 12.66M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.68×
EV/EBIT
—
Biotechnology median 26.56×
P/E (TTM)
—
Biotechnology median 7.21×